Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PCDH17 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
mRNA | PHIP | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
mRNA | CYSTM1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
mRNA | GPR25 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
mRNA | SVIL | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
mRNA | RASGEF1A | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
mRNA | RAB37 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | ADRA1D | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
mRNA | IRS1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
mRNA | POLR3F | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |